TOX and B-cell non-Hodgkin lymphoma: TOX gene expression in FL was then further analyzed in comparison to other B-cell lymphomas (MALT, SMZL, MCL and CLL) and reactive lymphoid tissue (lymph node and spleen), where we found significant TOX overexpression in FL for all tests (fold change >2, FDR <0.05.